Emergency anthrax treatment tested for future outbreaks
NCT ID NCT03569553
Summary
This study will evaluate the safety and effectiveness of a drug called AIGIV for treating people who develop inhalational anthrax after a major exposure event. It will only be activated if such a large-scale anthrax emergency occurs. Researchers will collect information on patient survival, illness severity, and any side effects from the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INHALATIONAL ANTHRAX are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.